Biotechnology Newswire
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
NEW YORK, May 9 PRNewswire-FirstCall — Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including...
WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting
OAKLAND, Calif., May 9 PRNewswire-FirstCall — (Nasdaq: WHRT, TSX: WHT) Since January 2008, World Heart Corporation (the "Company") has aggressively pursued various financing alternatives to raise additional capital, including through equity financing transactions and corporate...
SomaLogic and Otsuka Enter Into Research Collaboration
BOULDER, Colo., May 9 PRNewswire — SomaLogic, Inc. announced today that SomaLogic and Otsuka Pharmaceutical Co., Ltd. entered into a collaboration agreement to use SomaLogic's proprietary aptamer technology to discover and develop novel diagnostic products and to design research tools...
Bionovo Reports First Quarter 2008 Financial Results
EMERYVILLE, Calif., May 9 PRNewswire-FirstCall — Bionovo, Inc. (Nasdaq: BNVI) today announced results for the first quarter of 2008. Quarter Results The company did not report any revenue for the three months ended March 31, 2008. Revenues for the three months ended March 31, 2007...
Genaera Corporation Announces First Quarter Financial Results
PLYMOUTH MEETING, Pa., May 9 PRNewswire-FirstCall — Genaera Corporation (Nasdaq: GENR) today announced its financial results for the quarter ended March 31, 2008. The net loss for the quarter ended March 31, 2008 was $4.3 million, or $(0.24) per basic and diluted share, as compared to a...
Cardium Reports on First Quarter 2008 Highlights and Financial Results
SAN DIEGO, May 9 PRNewswire-FirstCall — Cardium Therapeutics (Amex: CXM) today reported recent highlights and developments, as well as financial results for its first quarter ended March 31, 2008. Highlights and Recent Developments — European commercialization agreement with...
Barr Announces Approval of Generic Yasmin(R)
MONTVALE, N.J., May 9 PRNewswire-FirstCall — Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture...
Notice of Time Change for Alexion's Presentation at the Bank of America 2008 Health Care Conference
CHESHIRE, Conn., May 9 PRNewswire-FirstCall — Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the time of Alexion's presentation at the Bank of America 2008 Health Care Conference in Las Vegas has been changed to 4:00 p.m., local time (7:00 p.m., eastern) on Tuesday...
Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
TAMPA, Fla., May 9 PRNewswire — The Cancer Research Alliance, an organization comprised of 12 of the nation's best cancer centers including Moffitt Cancer Center, is asking all 303 million Americans to exercise their power over cancer by stepping up and donating $1 to cancer research...
Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million
BEIJING and CLAREMONT, Calif., May 9 Xinhua-PRNewswire-FirstCall — Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced revenues for the first quarter of 2008 ended March 31 were $2,184,271, an increase of 57.8% above revenues of $1,384,093 for the first quarter...
Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
KENILWORTH, N.J., May 9 PRNewswire-FirstCall — Schering-Plough Corporation (NYSE: SGP) will hold its Annual Meeting of Shareholders Friday, May 16, 2008, in Memphis, Tenn. At 8 a.m. (CDT) (9 a.m. EDT) on that day, a live Webcast of the meeting will be available to all interested...
NeuroFocus Chief Science Advisor Wins Humboldt Prize
BERKELEY, Calif., May 9 PRNewswire — The Alexander von Humboldt Foundation, one of the world's leading sponsors of scientific research, announced that it has named Dr. Robert Knight as a winner of its highly prestigious Humboldt Research Award for 2008 in the area of neurobiology. It is...
Mother's Day is Devastating for Women Facing Infertility
Genetics & IVF Institute Offers Tips for Coping with the Holiday FAIRFAX, Va., May 9 PRNewswire-USNewswire — Mother's Day is excruciating for millions of women coping with infertility, which affects at least 6 million American women. "All of my clients dread Mother's Day," says...
Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
BASINGSTOKE, England and PHILADELPHIA, May 9 PRNewswire-FirstCall — Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that ordinary shareholders approved the scheme of arrangement proposed in a circular to shareholders dated 16 April 2008...
BioMS Medical Provides Update On Pipeline Products
EDMONTON, May 9 PRNewswire-FirstCall - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced an update on its pipeline products, HYC750 and development with BioCyDex Inc. The Company has entered into a Royalty and Assignment Agreement...
ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference
MINNEAPOLIS, May 9 PRNewswire-FirstCall — ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products, today announced that it will participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference at the Le Meridien Beach Plaza...
Genetic Immunity To Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
MCLEAN, Va. and BUDAPEST, Hungary, May 9 PRNewswire — Genetic Immunity, a US/Hungarian clinical-stage Company focused on the development of its patented nanomedicines for targeted immune amplification, announced today that the Company will be presenting at the Rodman & Renshaw 5th...
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
CALGARY, May 9 PRNewswire-FirstCall - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has begun patient enrolment in a clinical trial using intravenous administration of REOLYSIN(R) in combination with cyclophosphamide, a chemotherapeutic agent as well as...
Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager
FALL RIVER, Mass., May 9 PRNewswire — Millstone Medical Outsourcing announced today that the company successfully expanded its ISO 13485 certified quality system to the Memphis, TN, facility. (ISO, International Organization for Standardization, is the world's largest developer and...
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
PRINCETON, N.J., May 9 PRNewswire — Celator Pharmaceuticals today announced that Scott Jackson has been appointed Chief Executive Officer. Mr. Jackson joined Celator in October 2007 as Head of Commercial Development. "We are delighted to have Scott as the new CEO. He brings more...
Pulmo BioTech Announces an Increase in its Stake in PulmoScience
NEW YORK, May 9 PRNewswire-FirstCall — Pulmo BioTech Inc. (OTC Bulletin Board: PLMO) announced today that it has increased its stake in PulmoScience Inc. by 10%, taking its total holdings to 61% in this Company which owns a unique Molecular Imaging Diagnostic Technique for pulmonary...
International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
WASHINGTON, May 9 PRNewswire — The International Center for Adult Stem Cell Education (www.Adultstemcelleducation.com) today announced that it has officially launched a global communications and government-political affairs program at the 3rd International Spinal Cord Injury...
University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 PRNewswire — University Hospitals Case Medical Center and Cardialysis BV today announced that the Companies have the intention to found Cardialysis Cleveland to provide combined clinical drug development and medical imaging...
Cadient Group Brings Home the Gold at 2008 Aster Awards
WEST CONSHOHOCKEN, Pa., May 9 PRNewswire — Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, announced today it received two gold and one silver Aster Awards — which recognize the nation's most talented healthcare marketing...
Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
WALTHAM, Mass., May 9 PRNewswire-FirstCall — Inverness Medical Innovations (Amex: IMA) today announced that its previously announced acquisition of Matria Healthcare, Inc. was successfully completed and effective prior to the opening of business today, May 9, 2008. Matria...
InSet Technologies Appoints Jon Tremmel to its Board of Directors
MT. OLIVE, N.J., May 9 PRNewswire — InSet Technologies, an emerging leader in the development of implantable drug infusion pumps for targeted delivery of medications, announced today the addition of Jon Tremmel to its Board of Directors. Before retiring from Medtronic Inc. after...
Novavax Reports First Quarter 2008 Financial Results
ROCKVILLE, Md., May 9 PRNewswire-FirstCall — Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the first quarter 2008. Novavax reported a net loss of $7.8 million ($0.13 loss per share) for the first quarter of 2008 compared to a net loss of $8.4 million ($0.14 loss per...
China-Biotics, Inc. Completes Foundation for Its New Plant
SHANGHAI, China, May 9 Xinhua-PRNewswire-FirstCall — China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it...
Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
SAN DIEGO, May 9 PRNewswire-FirstCall — Ardea Biosciences, Inc. (Nasdaq: RDEA), a company focused on the discovery and development of small- molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout, today announced that John W. Beck has been...
InterMune to Present at Bank of America Health Care Conference
BRISBANE, Calif., May 9 PRNewswire-FirstCall — InterMune, Inc. (Nasdaq: ITMN) today announced that Dan Welch, President and Chief Executive Officer of InterMune, will present at the Bank of America 2008 Health Care Conference in Las Vegas on May 14, 2008 at 9:20 a.m. PDT (12:20 p.m...
Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
DANBURY, Conn., May 9 PRNewswire-FirstCall — Biodel Inc. (Nasdaq: BIOD) today reported financial results for its second quarter ended March 31, 2008. The net loss for the quarter was $9.6 million or $0.43 per share. "We remain on track in our development of VIAject(TM)," stated Dr...
SemBioSys announces first quarter 2008 financial and operational results
CALGARY, May 9 PRNewswire-FirstCall - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced its 2008 first quarter operational and financial results. Highlights - Prepared pilot...
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
ST. DAVID'S, Bermuda, May 9 PRNewswire-FirstCall — Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31, 2008 totaled $229.5 million, an increase of 5.1%, over the prior year quarter. The...
President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
SOUTHFIELD, Mich., May 9 PRNewswire — Dr. Michael W. Long recently was named the third-annual Grant Thornton Leader and Innovator of the Year. The "Leader & Innovator" award recognizes and rewards leaders and innovators in the state of Michigan who have demonstrated or created...
Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008
ST. LOUIS, May 9 PRNewswire-FirstCall — Stereotaxis, Inc. (Nasdaq: STXS) announced today that its participation at Heart Rhythm 2008 reflects the broad market leadership it has achieved as the only provider of fully automated, remote navigation technology for cardiac ablation. Of the...
EUSA Pharma Completes Acquisition Of Cytogen Corporation
DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 PRNewswire — EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its acquisition of Cytogen Corporation, following the...
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
OSAKA, Japan, and CAMBRIDGE, Mass., May 9 PRNewswire-FirstCall — Takeda Pharmaceutical Company Limited, "Takeda", (TSE: 4502) and Millennium Pharmaceuticals, Inc., "Millennium" (Nasdaq: MLNM) today announced the successful completion of Takeda's cash tender offer by its wholly-owned...
Northwest Secures US$4.0 Million in Debt Financing
BETHESDA, Md., May 9 PRNewswire-FirstCall — Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC Bulletin Board: NWBO), today announced that Al Rajhi Holdings W.L.L. ("Al Rajhi") has entered into an agreement, executed on May 6 2008, to provide NWBT with debt financing in the amount...
Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
MELBOURNE, Australia, May 9 PRNewswire-FirstCall — Cytopia Limited (ASX: CYT) today announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage drug discovery pipeline...
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
NEW YORK, May 8 PRNewswire-FirstCall — Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) will hold a conference call on Monday, May 12, 2008 at 8:30 a.m. EDT to discuss the first quarter 2008 financial results. Michael S. Weiss, Chairman and Chief Executive Officer of the Company, will host...
Halozyme Therapeutics Reports 2008 First Quarter Financial Results
SAN DIEGO, May 8 PRNewswire-FirstCall — Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today reported financial results for the three months ended March 31, 2008. "This year is off to...
CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008
SAN DIEGO, May 8 PRNewswire-FirstCall — CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced the reverse split of 1 for 7 shares of the Company's common stock was approved by its Shareholders at the Company's...
Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
IRVINE, Calif., May 8 PRNewswire-FirstCall — Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced that the company will celebrate a number of cardiac surgery milestones and product debuts at the 88th annual meeting of the American...
Alsius Corporation to Host First Quarter 2008 Financial Results Conference Call on May 15, 2008
IRVINE, Calif., May 8 PRNewswire-FirstCall — Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it will hold a conference call to discuss the Company's first quarter...
Pharmos Corporation Reports 2008 First Quarter Results
ISELIN, N.J., May 8 PRNewswire-FirstCall — Pharmos Corporation (Nasdaq: PARS) today reported results for the first quarter ended March 31, 2008. The Company recorded a net loss of $3.6 million, or $0.14 per share, for the first quarter 2008 compared to a net loss of $4.8 million, or...
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
SAN DIEGO, May 8 PRNewswire-FirstCall — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Bank of America 2008 Healthcare Conference on May 14, 2008 at 5:20 p.m. Pacific Time (8:20 p.m. Eastern Time) at the Four Seasons Hotel in...
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
SAN DIEGO, May 8 PRNewswire-FirstCall — NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that it has signed a definitive agreement to acquire the Osteocel biologics business...
Nova Biosource Fuels Presents at Merriman 4th Annual CleanTech Energy Conference
HOUSTON, May 8 PRNewswire-FirstCall — Nova Biosource Fuels, Inc. (Amex: NBF), a refiner and marketer of ASTM quality biodiesel, announced that its Vice Chairman, J.D. McGraw, will give a presentation on the Company, followed by a question and answer session, at the Merriman 4th Annual...
Mylan Reports Adjusted Diluted EPS of $0.09 for the Quarter Ended March 31, 2008
PITTSBURGH, May 8 PRNewswire-FirstCall — Mylan Inc. (NYSE: MYL) today announced its financial results for the three months ended March 31, 2008, the first quarter of its fiscal year ending December 31, 2008. Financial Highlights — Adjusted diluted EPS of $0.09 for the three months...
Favrille Reports First Quarter 2008 Financial Results
SAN DIEGO, May 8 PRNewswire-FirstCall — Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today reported its financial results for the first quarter ended March 31, 2008. Net loss for the quarter...
Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
SAN CARLOS, Calif., May 8 PRNewswire-FirstCall — Nuvelo, Inc. (Nasdaq: NUVO) today announced first quarter 2008 financial results and provided an updated outlook for 2008. For the first quarter ended March 31, 2008, Nuvelo reported a net loss of $18.4 million, or $0.34 per share...
Telik Announces First Quarter 2008 Financial Results
PALO ALTO, Calif., May 8 PRNewswire-FirstCall — Telik, Inc. (Nasdaq: TELK) today reported a net loss of $9.8 million, or $0.19 per share, for the first quarter ended March 31, 2008, compared with a net loss of $16.3 million, or $0.31 per share, for the comparable period in 2007. For the...
Pharsight Achieves $7.6 Million In Quarterly Revenue
MOUNTAIN VIEW, Calif., May 8 PRNewswire-FirstCall — Pharsight Corporation (Nasdaq: PHST), a leading provider of software and strategic services designed to optimize clinical drug development, today announced financial results for its fiscal fourth quarter and full year 2008, ended March...
Thermage Announces First Quarter 2008 Financial Results
HAYWARD, Calif., May 8 PRNewswire-FirstCall — Thermage, Inc. (Nasdaq: THRM), a leader in non-invasive tissue tightening in the aesthetic industry, reported today its financial results for the first quarter ended March 31, 2008. Revenue for the first quarter of 2008 was $16.2 million, up...
Anesiva Announces First Quarter 2008 Financial Results
SOUTH SAN FRANCISCO, Calif., May 8 PRNewswire-FirstCall — Anesiva, Inc. (Nasdaq: ANSV) today reported financial results and accomplishments for the first quarter ended March 31, 2008 and provided an update on its commercialization activities for FDA-approved Zingo(TM) (lidocaine...
Hologic to Present at the Bank of America Healthcare Conference
BEDFORD, Mass., May 8 PRNewswire-FirstCall — Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Bank of America Healthcare Conference being held May 13 - 15, 2008, at the Four Season Hotel in Las Vegas, NV. Interested parties...
Onyx Pharmaceuticals to Present at Bank of America Health Care Conference
EMERYVILLE, Calif., May 8 PRNewswire-FirstCall — Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Bank of America Health Care Conference on Thursday, May 15, at 11:50 a.m. Pacific Time. Interested parties may access a live webcast of the...
Maryland Stem Cell Research Commission Recommends 62 Projects for Funding
COLUMBIA, Md., May 8 PRNewswire-USNewswire — The Maryland Stem Cell Research Commission (Commission) has completed its evaluation of the 122 applications in response to its three official Requests for Applications (RFAs). The board of directors of the Maryland Technology Development...
Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
MIAMI, May 8 PRNewswire — Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world and a recognized leader in motion preservation technology, today announced the completion of enrollment in its SECURE(R)-C Cervical Artificial Disc IDE study. The...
Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
CAMBRIDGE, Mass., May 8 PRNewswire — In response to ever increasing cardiac toxicity found in market drugs, Gwathmey Preclinical Testing Services, Inc. today announced the launch of new Cardionomics(TM) services and the formation of its Cardionomics(TM) Advisory Board to provide new...
Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
ROCKVILLE, Md., May 8 PRNewswire-FirstCall — Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced that the company will deliver a...
AbelsonTaylor Captures DTC Gold
CHICAGO, May 8 PRNewswire — AbelsonTaylor, long known for its unorthodox and highly creative approach to healthcare advertising campaigns, scored top honors in the medical device category at the DTC National Advertising Awards on April 17. The ceremony was part of the DTC National...
Beckman Coulter to Present at Upcoming Healthcare Conferences
ORANGE COUNTY, Calif., May 8 PRNewswire-FirstCall — Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Paul Glyer, Beckman Coulter's Senior Vice...
Angiotech to participate in Bank of America Health Care Conference
VANCOUVER, May 8 PRNewswire-FirstCall - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the Bank of America 2008 Health Care Conference, which is being held May 13-15 in Las Vegas, Nevada...
Exelixis Announces May 13 Webcast of Presentation at the Bank of America Health Care Conference
SOUTH SAN FRANCISCO, Calif., May 8 PRNewswire-FirstCall — Exelixis, Inc. (Nasdaq: EXEL) announced today that George A. Scangos, PhD, president and chief executive officer of Exelixis, will present at the Bank of America 2008 Health Care Conference at 11:40 a.m. ET/8:40 a.m. PT on...
MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
ORCHARD PARK, N.Y., May 8 /PRNewswire-FirstCall/— MINRAD International, Inc. (Amex: BUF) announced today that the Company will hold an investor conference call to discuss first quarter 2008 financial results on Tuesday, May 13, 2008 at 4:30 PM ET. The Company will release first quarter 2008...
Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
MADISON, N.J., May 8 PRNewswire-FirstCall — Enterix Inc., a wholly-owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced the availability of the InSure(R) Quik F I T(TM) fecal immunochemical test, a point-of-care version of the company's lab-based InSure(R...
BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign
MANASQUAN, N.J., May 8 PRNewswire — BioSpace, the world's leading online bioscience job board and life science career fair company, unveiled this morning the 2008 Bio NC(TM) Hotbed Campaign for the bioscience industry in North Carolina. This unique campaign highlights the biotechnology...
Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
WASHINGTON, May 8 PRNewswire-FirstCall — Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder...
IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
BOSTON, May 8 PRNewswire — Informed Clinical Sciences (ICS) Advisory Services Corporation announced today the launch of the company's three-part Intellectual Property (IP) platform. This Platform suite offers content and instruments through a Medical Informatics Review, an Alliance...
/C O R R E C T I O N -- Insmed Inc./
The news release, Insmed (Nasdaq: INSM) Announces First Quarter 2008 Financial Results, issued earlier today by Insmed Inc., was incorrectly transmitted by PR Newswire. Complete, corrected release follows: Insmed Announces First Quarter 2008 Financial Results RICHMOND, Va., May 8...
Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
TAMPA, Fla., May 8 PRNewswire-FirstCall — Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced results from clinical trials that showed ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) capsules...
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
DEERFIELD, Ill., May 8 PRNewswire-FirstCall — Siemens Healthcare and Laboratory Corporation of America(R) Holdings (LabCorp(R)) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of...
LifeNet Health Chief Scientific Officer Wins Award
VIRGINIA BEACH, Va., May 8 PRNewswire-USNewswire — LifeNet Health, a leading allograft bio-implant company announces that Lloyd Wolfinbarger, Jr., Ph.D., was awarded an Excellence in Innovation award at the 11th Annual Hampton Roads Technology Council's Tech Nite in Hampton, Virginia...
Neurobiological Technologies Sets Date for Third Quarter Financial Results
EMERYVILLE, Calif., May 8 PRNewswire-FirstCall — Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII), today announced it will release its third quarter 2008 financial results, for the quarter ended March 31, 2008, on May 12, 2008 and host a conference call on May 13, 2008...
API and Raw Material Supply Concerns Focal Point of Pharma ChemOutsourcing Conference September 8-9 in New Jersey
LONG BRANCH, N.J., May 8 PRNewswire — When pharmaceutical and biotech chemistry sourcing management gathers in Long Branch, NJ in September to meet at the Pharma ChemOutsourcing Conference & Exhibition, areas of special interest will be starting materials and Active Pharmaceutical...
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
TAMPA, Fla., May 8 PRNewswire-FirstCall — Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that two studies to be presented this week at the American Pain Society annual meeting demonstrate the efficacy, tolerability and positive...
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
SAN DIEGO and BRUSSELS, Belgium, May 8 PRNewswire-FirstCall — Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and...
VIA Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
SAN FRANCISCO, May 8 PRNewswire-FirstCall — VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that James G. Stewart, senior vice president and chief financial officer, will...
CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
ATLANTA, May 8 PRNewswire — CorMatrix Cardiovascular, Inc., an Atlanta- based company dedicated to developing and delivering unique extracellular matrix (ECM(TM)) biomaterial technologies that harness the body's innate ability to repair damaged cardiovascular tissue, announced today...
Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
PITTSBURGH, May 8 PRNewswire — Applied Isotope Technologies ("AIT") announced today that the company's Biochemimarker(TM) Discovery Products will be exclusively used for the analyses of samples from autistic children for metabolic biochemical assessment when they are placed in an...
Amicus Therapeutics Announces First Quarter 2008 Results Release Date
CRANBURY, N.J., May 8 PRNewswire-FirstCall — Amicus (Nasdaq: FOLD) will announce first quarter 2008 financial results after the regular close of markets on Tuesday, May 13, 2008. The results announcement will be followed by a live conference call and webcast that afternoon at 5 p.m...
Genaera Corporation Announces Initiatives to Conserve Resources to Continue Development Efforts
PLYMOUTH MEETING, Pa., May 8 PRNewswire-FirstCall — Genaera Corporation (Nasdaq: GENR) today announced plans that will enable the Company to continue development efforts over the next 12 months for its trodusquemine (MSI-1436) type 2 diabetes and obesity program, and the MEDI-528...
New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
SMYRNA, Ga., May 8 PRNewswire — Patients treated with lacosamide demonstrated sustained pain relief from diabetic neuropathic pain (DNP), compared to placebo-treated patients, according to data presented at the 27th annual meeting of the American Pain Society (APS) in Tampa, Fla...
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
WILMINGTON, Del., May 8 PRNewswire-FirstCall — AstraZeneca (NYSE: AZN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets to seek approval for...
Mac-Gray Corporation Announces First-Quarter 2008 Financial Results
WALTHAM, Mass., May 8 PRNewswire-FirstCall — Mac-Gray Corporation (NYSE: TUC), the nation's premier provider of laundry facilities management services to multi-unit housing locations, today announced its financial results for the first quarter ended March 31, 2008. Mac-Gray reported...
ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended April 30, 2008 and Provide a Business Update
ADDISON, Texas, May 8 PRNewswire-FirstCall — ULURU Inc. (Amex: ULU) today announced that it has scheduled a conference call to discuss the first quarter 2008 financial results and provide a general business update on Monday, May 12, 2008 at 10:00 a.m. Eastern Daylight Time. To...
ALCiS(R) Racing Team Breaks Records at Wildflower Triathlon
SAN JOSE, Calif., May 8 PRNewswire — The ALCiS Racing Team made significant strides at the 2008 Avia Wildflower Triathlon on Saturday. ALCiS' Nicholas Thompson was crowned 'Overall Men's Amateur Champion' as he broke the all-time men's amateur course record by over four minutes...
Sunesis Pharmaceuticals Reports First Quarter 2008 Financial Results
SOUTH SAN FRANCISCO, Calif., May 8 PRNewswire-FirstCall — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule therapeutics, today reported financial results for the...
BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
BRISBANE, Calif., May 8 PRNewswire — BiPar Sciences, Inc. today announced the expansion of Phase 2 clinical trial programs for its lead product, BSI-201, in ovarian cancer. This is the third major clinical trial of BSI-201 that BiPar has launched in the past 6 months, expanding on...
Jazz Pharmaceuticals, Inc. Secures $75 Million Committed Equity Financing Facility
PALO ALTO, Calif., May 8 PRNewswire-FirstCall — Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that it has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a private investment group, in which Kingsbridge has committed to provide...
Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
HUDSON, N.H., May 8 PRNewswire — Atrium Medical Corporation is pleased to announce it has obtained US FDA 510(K) approval for two new Omega 3 surgical mesh products; C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch. These new products are indicated for use in the surgical repair and...
BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
BIRMINGHAM, Ala., May 8 PRNewswire-FirstCall — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced financial results for the quarter ended March 31, 2008. The Company reported revenues of $10.8M in the first quarter of 2008, compared to $9.2M in the first quarter of 2007...
Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
CRANBURY, N.J., May 8 PRNewswire-FirstCall — Palatin Technologies, Inc. (Amex: PTN) will announce its third quarter, fiscal year 2008 financial results for the period ended March 31, 2008 before the open of the U.S. financial markets on May 13, 2008. The Company will also conduct a...
Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008
DOYLESTOWN, Pa., May 8 PRNewswire —- Prescient Medical, Inc., a privately held medical device company dedicated to reducing deaths from heart attacks, will present new experimental results on the chemical characterization and treatment of rupture-prone or "vulnerable" plaques, with a...
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
MONTVALE, N.J., May 8 PRNewswire-FirstCall — Barr Pharmaceuticals, Inc. (NYSE: BRL) today reported net earnings of $23 million, or $0.21 per share, on revenues of $608 million for the quarter ended March 31, 2008. The current quarter results compare with prior year net earnings of $12...
Atherotech to Exhibit the VAP Test at Internal Medicine 2008
BIRMINGHAM, Ala., May 8 PRNewswire — Atherotech, Inc., a cardio-diagnostic company, today announced it will be exhibiting its VAP Cholesterol Test in booth No. 2123 at the American College of Physicians (ACP) Internal Medicine 2008, the premier scientific meeting for internal...
Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
BERKELEY HEIGHTS, N.J., May 8 PRNewswire-FirstCall — Genta Incorporated (OTC Bulletin Board: GNTA) today announced financial results for the quarter ended March 31, 2008. From the beginning of the year, the Company has recorded significant milestones including the following: &mdash...
Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed's Selective Kinase Inhibitor
ROCKVILLE, Md., May 8 PRNewswire-FirstCall — EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that Dana-Farber Cancer Institute has joined the University of Colorado...
Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
PALO ALTO, Calif., May 8 PRNewswire — Anacor Pharmaceuticals announced today that it will present six posters on topical anti-inflammatory candidates, AN2728 and AN2898, at the upcoming International Investigative Dermatology 2008 Conference, taking place May 14-17, 2008 in Kyoto...
Dendreon Reports First Quarter 2008 Financial Results
SEATTLE, May 8 PRNewswire-FirstCall — Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2008. Revenue for the first quarter of 2008 was $31,000 compared to $80,000 for the quarter ended March 31, 2007. Dendreon's total operating expenses...
BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
BOTHELL, Wash., May 8 PRNewswire-FirstCall — BioLife Solutions Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that its Master File for CryoStor...
Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results
PURCHASE, N.Y., May 8 PRNewswire-FirstCall — Nutrition 21, Inc. (Nasdaq: NXXI), the developer and marketer of nutritional supplements under the Iceland Health(R), Chromax(R), Advanced Memory Formula(TM) and Diabetes Essentials(TM) — brands that help consumers manage blood sugar...
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
LEVERKUSEN, Germany, MONTVILLE, New Jersey and TARRYTOWN, New York, May 8 /PRNewswire-FirstCall/ — Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first patient has been dosed in the VIEW 2 trial, a second Phase 3 clinical study in a...
James T. Glover Appointed to Board of Directors of Varian, Inc.
PALO ALTO, Calif., May 7 PRNewswire-FirstCall Varian, Inc. (NasdaqGS: VARI) announced that its Board of Directors today appointed James T. Glover as a new director. Glover is the seventh member of Varian, Inc.'s board of directors, and was appointed for a term expiring at the annual...
ImaRx Schedules Release of First Quarter 2008 Financial Results
TUCSON, Ariz., May 7 PRNewswire-FirstCall — ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today announced that the Company will host a live webcast and conference call on Tuesday, May 13, 2008, at 5:00 p.m. ET to discuss first quarter 2008 financial results. The live webcast can be accessed...
BD to Present at Investor Healthcare Conferences
FRANKLIN LAKES, N.J., May 7 PRNewswire-FirstCall — BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it would present at the following investor healthcare conferences: Bank of America 2008 Healthcare Conference May 14, 2008 11:40...
FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation
WOODCLIFF LAKE, N.J., May 7 PRNewswire — Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetic and Life Support Drugs (ALSDAC) has voted 6 to 3 in favor (with one...
Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
SEATTLE, May 7 PRNewswire — Amnis Corporation and Gene Company, Ltd. announced today the completion of an agreement under which Gene Company will sell and service the Amnis ImageStream(R) system in China. Effective immediately, the scientific research communities in Hong Kong...
Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008
MONTVALE, N.J., May 7 PRNewswire-FirstCall — Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that it will report its first quarter 2008 financial results on Wednesday, May 14, 2008, before the U.S. financial markets open. Management will provide a Company update and discuss...
Mindray Medical International Announces First Quarter 2008 Results
SHENZHEN, China, May 7 Xinhua-PRNewswire-FirstCall — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced its selected unaudited financial results for...
Group Hotel Rate Ends Friday: Reserve Now for Leadership Development Conference June 4-6
CHAPEL HILL, N.C., May 7 PRNewswire — Building a comprehensive and coherent corporate brand and positioning that attracts talent from the competitive marketplace is a critical step to developing a pipeline of potential high-performers. This plus recruiting, developing, retaining and...
Quintiles Signs Agreement to Acquire Eidetics
RESEARCH TRIANGLE PARK, N.C., May 7 PRNewswire — Quintiles Transnational Corp. today announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting...
Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
ST. LOUIS, May 7 PRNewswire-FirstCall — Sigma-Aldrich(TM) (Nasdaq: SIAL) and the second phase of The RNAi Consortium (TRC2) have commenced functional validation of the Consortium's collection of approximately 160,000 previously-cloned lentiviral-based shRNA vector constructs. Currently...
Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
SAN CARLOS, Calif., May 7 PRNewswire-FirstCall — Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Patent and Trademark Office has issued Patent No. 7,368,102, which covers compositions and methods for creating and delivering Tobramycin Inhalation Powder (TIP) and other...
Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference
SAN DIEGO, May 7 PRNewswire-FirstCall — Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Bank of America Healthcare Conference on Tuesday, May 13, 2008 at 10:00 a.m. PT in Las Vegas. Michael York, Senior Director of Investor Relations of Amylin Pharmaceuticals, will...
Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
SAN DIEGO, May 7 PRNewswire-FirstCall — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the first quarter ended March 31, 2008. Total revenues in the first quarter of 2008 were $2.6 million, compared to $4.9 million in the first quarter of 2007, and...
Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
SAN DIEGO, May 7 PRNewswire-FirstCall — Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary...
Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
WALTHAM, Mass., May 7 PRNewswire-FirstCall — Interleukin Genetics, Inc. (AMEX: ILI), announced today that it will host a conference call and webcast on Wednesday, May 14, 2008 at 4:30 p.m. ET to review the Company's first quarter 2008 financial results and provide an update on recent...
Pharmacopeia Announces First Quarter 2008 Financial Results
PRINCETON, N.J., May 7 PRNewswire-FirstCall — Pharmacopeia (Nasdaq: PCOP) today announced results for the quarter ended March 31, 2008. Recent company developments have included the following: — Pharmacopeia announced the completion of enrollment in a multi-center Phase 2a...
Transgenomic, Inc. Reports First Quarter 2008 Results
OMAHA, Neb., May 7 PRNewswire-FirstCall — Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced financial results for the quarter ended March 31, 2008. The Company's financial results are presented in the tables that follow. The Company reported net income of $122,000 or $0.00...
Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
SAN DIEGO, May 7 PRNewswire-FirstCall — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that Taisho Pharmaceutical Co., Ltd. initiated a Phase 1 clinical trial of a drug candidate under a GPCR-focused partnership with Arena to develop compounds to treat psychiatric disorders...
Replidyne Announces First Quarter 2008 Earnings Results
LOUISVILLE, Colo., May 7 PRNewswire-FirstCall — Replidyne, Inc. (Nasdaq: RDYN) today announced its financial results for the first quarter ended March 31, 2008. Replidyne reported a net loss of $9.0 million for the first quarter ended March 31, 2008, or a net loss per basic and...
ThermoGenesis Corp. Announces Third Quarter Fiscal 2008 Results
RANCHO CORDOVA, Calif., May 7 PRNewswire-FirstCall — ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, today reported results for the third quarter and first nine months of fiscal 2008. Separately, the...
Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
SEATTLE, May 7 PRNewswire-FirstCall — Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that its partner, Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), has commenced patient dosing in the next Phase 2b clinical trial of TRU-015 in patients with rheumatoid arthritis...
Dutch Authorize Manufacture of Vaccinogen's New Cancer Vaccine; License Clears Path to European Production, Final FDA Trial
FREDERICK, Md., May 7 PRNewswire — Vaccinogen Inc. said Dutch health authorities licensed it to manufacture its break-through OncoVAX anti-colon cancer vaccine, immediately clearing the path to more than $100 million of potential European sales. The Dutch approval of the company's...
Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
CAMBRIDGE, Mass., May 7 PRNewswire-FirstCall — Genzyme Corp. (Nasdaq: GENZ) reported today that a preliminary analysis of data from an ongoing open-label Phase 2 clinical trial of its investigational oral therapy Genz-112638 showed that the compound produced a meaningful impact on key...
New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
WASHINGTON, May 7 PRNewswire-FirstCall — Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA(TM) (methylphenidate transdermal system...
VWR Funding, Inc. to Hold First Quarter 2008 Financial Results Conference Call
WEST CHESTER, Pa., May 7 PRNewswire — VWR Funding, Inc., the parent company of VWR International, LLC, a leading global laboratory supply company, will hold a conference call on Monday, May 19th to discuss its first quarter financial results. Who: John M. Ballbach, Chairman, President...
Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
WEST PORT, Conn., and SCOTTSDALE, Ariz., May 7 PRNewswire — Advanced BioHealing, Inc. (ABH) and Regenesis Biomedical, Inc. announced today an agreement focused on the promotion of Dermagraft(R) within the United States (US) government healthcare system. Under terms of the agreement...
Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
WASHINGTON, May 7 PRNewswire-FirstCall — Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented today at a major scientific meeting findings from analyses of pivotal trial results of INTUNIV, a selective alpha-2A-agonist. This compound is an...
Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
ABBOTT PARK, Ill., May 7 PRNewswire-FirstCall — Abbott (NYSE: ABT) and other leading scientists will present new Phase II data showing that ABT-089, a selective neuronal nicotinic receptor (NNR) agonist, is a potentially effective and safe treatment for adults with Attention-Deficit...
Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
MALIBU, Calif., May 7 PRNewswire — Pathway Diagnostics announces nationwide availability of its patented second generation molecular SensiTrop(TM) II assay, combining the sensitivity of molecular heteroduplex tracking assay (HTA) technology with the specificity of molecular sequencing...
West Announces Third Quarter 2008 Dividend
LIONVILLE, Pa., May 7 PRNewswire-FirstCall — West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved a third quarter 2008 cash dividend of $0.14 per share. The dividend will be paid on August 6, 2008 to shareholders of record on July 23, 2008...
Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign
STAMFORD, Conn., May 7 PRNewswire — Every two minutes a woman in the United States is diagnosed with breast cancer(1). In New York City alone, more than 5,000 women are diagnosed with breast cancer annually and nearly 1,200 die from the disease(2). While annual mammograms are...
Arpida Annual General Meeting of Shareholders Approves All Board Proposals
REINACH, Switzerland, May 7 PRNewswire-FirstCall — The Annual General Meeting of Arpida Ltd (SWX: ARPN) has approved the proposals that were put forward by the Board of Directors. A total of 73 shareholders were present at the meeting that took place in Basel today. 6,186,266 shares...
U.S. Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
CHAPEL HILL, N.C., May 7 PRNewswire — In today's marketplace, pharmaceutical and biotechnology companies are experiencing intense pricing, political, regulatory and market pressures. These forces are creating stress on the industry's fundamental business model. Consequently...
Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting
NEW BRUNSWICK, N.J., May 7 PRNewswire-FirstCall — Johnson & Johnson will provide a pre-recorded webcast for financial analysts on Friday, May 9 at 4:00 p.m. (Eastern Time) to coincide with the American Pain Society's (APS) annual meeting in Tampa, Fla. Phase 3 clinical data...
Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
WESTBOROUGH, Mass., May 7 PRNewswire — IBC Life Sciences announced the keynote line up for the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress, to take place August 4-7, 2008 in Boston, MA. The keynote presentations will include speakers David M...
Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
MELVILLE, N.Y., May 7 PRNewswire — Nikon Instruments, Inc. (www.nikoninstruments.com) is pleased to announce that it has begun direct sales and technical support for Nikon's BioScience Microscopes, Confocal Systems and Digital Imaging products, along with Industrial products including...
NeurogesX to Report First Quarter 2008 Financial Results
SAN MATEO, Calif., May 7 PRNewswire-FirstCall — NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will report results for its first quarter 2008 on Thursday, May 15, 2008, before...
NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
SAN CARLOS, Calif., May 7 PRNewswire-FirstCall — New Phase 1 clinical trial results for NKTR-118 (oral PEG-naloxol) were presented by Nektar Therapeutics (Nasdaq: NKTR) this week at the Annual Meeting of the American Pain Society (APS) in Tampa, Florida. In this multiple-dose Phase 1...
BioMarin to Present at the Bank of America Healthcare Conference
NOVATO, Calif., May 7 PRNewswire-FirstCall — BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Bank of America Healthcare Conference in Las Vegas on Wednesday, May 14...
Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million
PITTSBURGH, May 7 PRNewswire — Cohera Medical, Inc., a rapidly growing medical device company developing a suite of wound management systems and surgical adhesives, announced today that it has closed an insider round of financing for over $7.6 Million. The proceeds of this transaction...
Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
CEDAR KNOLLS, N.J., May 7 PRNewswire-FirstCall — Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced its financial results for the first quarter ended March 31, 2008. Emisphere will host a conference call to discuss first quarter results at 10:00 AM EDT Wednesday, May 7, 2008. A...
Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
ARLINGTON, Va., May 7 PRNewswire-FirstCall — Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced that it has established an...
Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
NATICK, Mass., May 7 PRNewswire-FirstCall — Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA(TM) family of pacemakers. ALTRUA is Boston Scientific's most advanced pacemaker and delivers enhanced therapies while maintaining its...
XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
MENLO PARK, Calif., May 7 PRNewswire-FirstCall — XTENT, Inc. (Nasdaq: XTNT) today announced that six-month follow-up data from the CUSTOM III trial will be presented at EuroPCR, taking place May 13 to 16 in Barcelona. The company will hold a webcast and conference call to review the...
Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
WASHINGTON, May 7 PRNewswire-FirstCall — Patients receiving paliperidone extended-release tablets (paliperidone ER) spent significantly fewer days in the hospital, had significantly fewer emergency room and psychiatric-related office visits, and fewer psychotherapy sessions, compared...
Oncothyreon Reports First Quarter 2008 Financial Results
BELLEVUE, WA, May 7 PRNewswire-FirstCall - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) (the "Company") today reported a net loss of $5.1 million or $0.26 per basic and diluted share for the quarter ended March 31, 2008, compared with $4.7 million or $0.24 per basic and diluted share for the...
ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
TUCSON, Ariz., May 7 PRNewswire-FirstCall — ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today announced that it has signed a letter of intent in which Microbix Biosystems will acquire urokinase inventory and related assets from ImaRx for $17 million in cash. Urokinase is an FDA-approved...
Neuralstem Sues StemCells, Inc. Over New Patent
ROCKVILLE, Md., May 7 PRNewswire-FirstCall — Stem cell company Neuralstem, Inc. (Amex: CUR) is filing suit today against StemCells, Inc. stating, among other things, that StemCells intentionally withheld crucial information highly material to the patentability of StemCells' "new" patent...
Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
PITTSBURGH, May 7 PRNewswire-FirstCall — Mylan Inc. (NYSE: MYL) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ropinirole Hydrochloride Tablets, 0.25 mg...
Entrust Chairman, President and CEO Bill Conner to Present at 8th Annual State of Technology Luncheon
DALLAS, May 7 PRNewswire-FirstCall — Entrust, Inc. (Nasdaq: ENTU) Chairman, President and CEO Bill Conner will present at the 8th Annual State of Technology Luncheon on Thursday, May 8, at 12 p.m. CDT, at Sheraton Dallas Hotel in Dallas, Texas. Conner will address the history of attacks...
Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
BEIJING, May 7 Xinhua-PRNewswire — Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that Mr. Weidong Yin, CEO, and Ms. Helen Yang, International Business Manager, are scheduled to present at the Brean Murray, Carret & Co. All-Cap All-China...
Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
PALO ALTO, Calif., May 7 PRNewswire-FirstCall — Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its first quarter 2008 financial results on May 13, 2008, following the close of the U.S. financial markets. Jazz Pharmaceuticals will host an investor...
Pharm-Olam Finds VoIP Solution in Taridium LLC
NEW YORK, May 7 PRNewswire — When leading contract research organization Pharm-Olam International (POI, http://www.pharm-olam.com) upgraded its legacy PBX system to a voice-over Internet protocol (VoIP) system that would better serve the company's global communications needs, the...
Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
OMAHA, Neb., April 22 PRNewswire-FirstCall — Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast: What: Transgenomic Inc. First Quarter 2008 Earnings Release Conference Call When: Wednesday, May 7, 2008 @ 5:00 p.m. Eastern Where...
AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
QUEBEC CITY, May 7 PRNewswire-FirstCall - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results for the first quarter ended March 31, 2008. First Quarter 2008 Highlights...
Nventa Appoints John Varian to Board of Directors
SAN DIEGO, May 7 PRNewswire-FirstCall — Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the appointment of John Varian to the company's board of directors. Mr. Varian currently serves as the chief operating officer and chief financial officer of Aryx Therapeutics, a...
iCAD Reports First Quarter 2008 Financial Results
NASHUA, N.H., May 7 PRNewswire-FirstCall — iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced financial results for the three months ended March 31, 2008. Financial highlights for...
SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System
ORANGE, Conn., May 7 PRNewswire — SurgiQuest, Inc. today announced the first single port laparoscopic removal of an ovary using the AirSeal(TM) access system. Drs. Anthony Discuillo and Christopher Awtry performed the procedure at Mount Auburn Hospital in Cambridge, MA. The AirSeal...
Advanced Life Sciences Announces First Quarter 2008 Financial Results
CHICAGO, May 7 PRNewswire-FirstCall — Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases, today announced...
American Oriental Bioengineering Reports First Quarter 2008 Financial Results
NEW YORK, May 7 PRNewswire-FirstCall — American Oriental Bioengineering, Inc. (NYSE: AOB), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China...
NovaDel Announces $4 Million Financing
FLEMINGTON, N.J.-(Business Wire)-May 6, 2008 - NovaDel Pharma Inc. (AMEX: NVD) announced today that it has entered into definitive agreements for the private placement with certain accredited investors (the "Purchasers") for an aggregate of up to $4 million in gross proceeds, in the form of...
Nation's Largest Medical Specialty Organization Issues New Guideline for Screening for Osteoporosis in Men
PHILADELPHIA-(Business Wire)-May 6, 2008 - Osteoporosis is often viewed as a women's health issue, but one in 16 men over 65 suffers from the disease, and few men are currently tested or diagnosed. Because of the aging population, a dramatic increase in osteoporosis among men is expected in the near...
Allos Therapeutics to Present at the Bank of America 2008 Healthcare Conference
WESTMINSTER, Colo.-(Business Wire)-May 6, 2008 - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing small molecule therapeutics for the treatment of cancer, today announced that members of the Company's senior management will present a...
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-May 6, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentations at the Bank of America 2008 Health Care Conference on Tuesday, May 13, 2008 at 1:20 p.m. PDT and at Robert W. Baird & Co.'s 2008...
Charles River Announces First-Quarter 2008 Results
WILMINGTON, Mass.-(Business Wire)-May 6, 2008 - Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2008. For the quarter, net sales increased 16.0% to $337.7 million from $291.2 million in the first quarter of 2007. Both the Research Models...
OSI Pharmaceuticals Announces First Quarter 2008 Financial Results
MELVILLE, N.Y.-(Business Wire)-May 6, 2008 - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today its financial results for the Company's first quarter ended March 31, 2008. The Company reported net income from continuing operations of $31.7 million (or $0.52 per share) for the three months...
Conceptus Reports First Quarter Net Sales Up 53%
MOUNTAIN VIEW, Calif.-(Business Wire)-May 6, 2008 - Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure(R) procedure, the first and only non-incisional permanent birth control method available, today reported financial results for the three months ended March 31, 2008. Net sales for the first...
Applied Biosystems to Webcast Presentations at Two Investment Conferences
FOSTER CITY, Calif.-(Business Wire)-May 6, 2008 - Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its presentations at two upcoming financial conferences. Applied Biosystems Group will webcast its presentation at the Robert W. Baird 2008 Growth Stock Conference...
Targacept Reports First Quarter 2008 Financial Results
WINSTON-SALEM, N.C.-(Business Wire)-May 6, 2008 - Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics(TM), today reported its financial results for the first quarter ended March 31, 2008. Targacept reported a net loss...
OraSure Technologies Announces 2008 First Quarter Results
BETHLEHEM, Pa.-(Business Wire)-May 6, 2008 - OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $18.1 million for the three months ended March 31, 2008, compared to $20.1 million in revenues recorded for the three months ended...
Northstar Neuroscience to Present at Bank of America 2008 Healthcare Conference
SEATTLE-(Business Wire)-May 6, 2008 - Northstar Neuroscience, Inc. (NASDAQ:NSTR) today announced that John Bowers, Northstar's President and Chief Executive Officer, will present at Bank of America's 2008 Healthcare Conference May 13-15, 2008 at the Four Seasons Hotel, Las Vegas, Nevada. Mr...
Cutera(R) Reports First Quarter 2008 Results
BRISBANE, Calif.-(Business Wire)-May 6, 2008 - Cutera, Inc. (NASDAQ:CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended March 31, 2008. First quarter 2008 revenue was $21.6 million...
Basil Zimmo Joins Finesse Solutions as Vice-President of Software
SANTA CLARA, Calif., May 6 PRNewswire — Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of...
MaxWell USA, LLC Holds First Annual International Symposium on Medical/Pharmaceutical Research and Business in the Commonwealth of Independent States
WASHINGTON-(Business Wire)-May 6, 2008 - MaxWell USA, LLC will hold its first annual international symposium on medical and pharmaceutical research and business in the Commonwealth of Independent States (CIS) on Wednesday, May 28, 2008, at the Ritz-Carlton Hotel in downtown Washington, D.C. The...
AlphaMed Awarded $750,000 Grant for Its Targeted Melanoma Therapy
ACTON, Mass.-(Business Wire)-May 6, 2008 - AlphaMed Inc. has been awarded a $750,000 peer review grant from the National Cancer Institute to continue development of its targeted melanoma therapy. Funds from this grant will be used to develop an imaging capability required for treatment planning. For...
Meda AGM Bulletin
SOLNA, Sweden-(Business Wire)-May 6, 2008 - Regulatory News: The Annual General Meeting of Meda AB (publ), corporate ID 556427-2812, Box 906,SE-170 09 Solna, Sweden, on Tuesday, May 6, 2008, resolved that the dividend for the 2007 financial year will be SEK 0.75 per share. The AGM adopted the...
BIO Announces Call for Paper and Panel Submissions for 2008 Pacific Rim Summit on Industrial Biotechnology and Bioenergy
WASHINGTON-(Business Wire)-May 6, 2008 - The Biotechnology Industry Organization (BIO) invites leaders from biotechnology, chemical and agricultural industries to submit proposals for panels and individual papers for the third annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy...
Invacare CEO, A. Malachi Mixon, III, and President & COO, Gerald B. Blouch, Presenting at Bank of America 2008 Healthcare Conference
ELYRIA, Ohio-(Business Wire)-May 6, 2008 - A. Malachi Mixon, III, Chairman and Chief Executive Officer, and Gerald B. Blouch, President and Chief Operating Officer, of Invacare Corporation (NYSE:IVC), will present at the Bank of America 2008 Healthcare Conference in Las Vegas, Nevada on Tuesday, May...
SalesForce4Hire(R) Expands Strategic Focus in Surgical Markets
CARY, N.C.-(Business Wire)-May 6, 2008 - SalesForce4Hire, LLC (www.salesforce4hire.com), based in Cary, NC, is expanding the role of Philip Rich by promoting him to the newly created position of Director of Sales, Surgical Markets. Rich brings nearly a decade of experience working with independent...
ResuscitationCentral.com Breaking News Feature Now Powered by MedIntelliBase(R) Custom Alerts
REDMOND, Wash.-(Business Wire)-May 6, 2008 - Visitors to ResuscitationCentral.com can get free weekly clinical resuscitation abstracts through its Breaking News page. The Breaking News feature, powered by MedIntelliBase Custom Alerts, provides a live RSS feed of valuable clinical resuscitation...
Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition
PITTSBURGH, May 6 PRNewswire — For the ninth time, a team of students from the Tepper School of Business at Carnegie Mellon have landed the top prize this past weekend at leading business plan competition Moot Corp(R). This year's winning venture business — NeuroBank — has...
LifeQuest World Launches Immune System Boosting Supplement to the North American Market
LAS VEGAS, May 6 PRNewswire-FirstCall — LifeQuest World Corporation (OTC Bulletin Board: LQWC) is pleased to announce that after 7 months of preparatory work, ImmunXT, their Immune System enhancement supplement, has been released for sale to the North American Market as of March...
Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
SOUTH SAN FRANCISCO, Calif., May 6 PRNewswire-FirstCall — Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today reported on its corporate progress and financial results for the first quarter ended March 31, 2008. "During the first...
Brief Exposure to Second-Hand Smoke Bad for Health According to New Study
HASBROUCK HEIGHTS, N.J.-(Business Wire)-May 6, 2008 - Nymox Pharmaceutical Corporation (NASDAQ: NYMX) offers TobacAlert(TM) Urine, an easy-to-use test for second-hand smoke exposure that requires no special equipment or training and can be used for at home or at the workplace. A new study has...
Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
BERKELEY HEIGHTS, N.J., May 6 PRNewswire-FirstCall — Genta Incorporated (OTC Bulletin Board: GNTA) announced today that it has been advised that the Financial Industry Regulatory Authority (FINRA, formerly, the NASD) has cleared a market maker's Form 211 application to quote the...
PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
ANNAPOLIS, Md., May 6 PRNewswire-FirstCall — PharmAthene, Inc. (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the first quarter of 2008 will be released on Tuesday, May 13, 2008...
Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
COLUMBUS, Ohio, May 6 PRNewswire-USNewswire — Developing a strong pharmaceutical industry is a key issue in Korea. So much so, that Battelle-Korea, Battelle, Chuncheon City, Gangwon Province and YuYu Inc., intend to collaborate and address the issue. A Korean corporation named...
Sigma-Aldrich Shareholders Elect Directors and Ratify Auditor; Directors Declare Quarterly Dividend
ST. LOUIS, May 6 PRNewswire-FirstCall — At the annual shareholders meeting of Sigma-Aldrich Corporation (Nasdaq: SIAL) held today in St. Louis, the following directors were re-elected: David R. Harvey, W. Lee McCollum, Jai P. Nagarkatti, Avi M. Nash, Steven M. Paul, J. Pedro...
AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards
TORONTO, May 6 PRNewswire-FirstCall - Lorus Therapeutics Inc. ("Lorus" or the "Company") (TSX: LOR; AMEX: LRP), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, has received a notice from the...
SGX Pharmaceuticals Schedules Teleconference and Webcast to Discuss First Quarter 2008 Results and Provide Pipeline Update
SAN DIEGO, May 6 PRNewswire-FirstCall — SGX Pharmaceuticals (Nasdaq: SGXP) will announce financial results for the first quarter of 2008 on Tuesday May 13, 2008. The announcement will be followed by a live conference call and webcast at 8:00 a.m. Pacific Time on that same day. Mike...
Exelixis Announces First Quarter 2008 Financial Results
SOUTH SAN FRANCISCO, Calif., May 6 PRNewswire-FirstCall — Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter ended March 31, 2008. Revenues for the quarter ended March 31, 2008 were $27.9 million, compared to $28.1 million for the comparable period in...
Sigma-Aldrich to Present at the Bank of America 2008 Healthcare Conference on Tuesday, May 13, 2008
ST. LOUIS, May 6 PRNewswire-FirstCall — Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the Bank of America 2008 Healthcare Conference on Tuesday, May 13th at 10:40 AM Pacific Time in Las Vegas, Nevada. Interested parties may listen via live audio broadcast over the...
LifeCycle Pharma Appoints Dr. Karin Hamberg as Executive Vice President of Research and Development
HORSHOLM, Denmark-(Business Wire)-May 6, 2008 - LifeCycle Pharma A/S (OMX:LCP) announced today the appointment of Dr. Karin Hamberg as Executive Vice President for Research and Development effective June 1, 2008. Mrs. Hamberg will be responsible for Drug Delivery Research and Alliance &...
Genomic Health Announces First Quarter 2008 Financial Results and Business Progress
REDWOOD CITY, Calif., May 6 PRNewswire-FirstCall — Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2008. Total revenue increased to $23.4 million in the first quarter of 2008 compared to $14.1 million in the...
Baxter's Board of Directors Declares Quarterly Dividend
DEERFIELD, Ill., May 6 PRNewswire-FirstCall — The Board of Directors of Baxter International Inc. (NYSE: BAX) today announced a quarterly dividend and votes taken at the company's Annual Meeting of Shareholders held earlier today. Baxter's Board of Directors declared a quarterly...
Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
HAYWARD, Calif., May 6 PRNewswire-FirstCall — Kosan Biosciences Incorporated (Nasdaq: KOSN) announced today that Jane Green, Kosan's Vice President, Corporate Communications, will present at the Leerink Swann Solid Tumors Roundtable Conference in New York at the Grand Hyatt Hotel on...
Search Our News Using Google Search
Can't find what you want? Try using Google:
